Pharmacogenomics
Future Medicine
About the journal
Pharmacogenomics is a journal published by Future Medicine in United Kingdom. It is listed in MEDLINE and PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Future Medicine
- ISSN
- 1462-2416 · 1744-8042
- Country
- United Kingdom
- Access
- Not open access / not declared
Index listings
- MEDLINE · 2000-01-01
- PUBMED · 2017-07-26
- Indexing
- MEDLINE · PUBMED
- APC
- —
- Declared review time (DOAJ)
- —
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
3746
Last recorded publication year
2026
h-index
111
i10-index
2020
From OpenAlex open data (CC0).
Editorial & policy5
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 98%
- ORCID iDs in current deposits
- 58%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 100897350
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Pharmacogenetics and Drug Metabolism
- Pharmacogenetics and Drug Metabolism
- Drug Transport and Resistance Mechanisms
- Drug Transport and Resistance Mechanisms
- Genetic Associations and Epidemiology
- Genetic Associations and Epidemiology
- Pharmaceutical studies and practices
- Pharmaceutical studies and practices
Show all subjects (50)
- Computational Drug Discovery Methods
- Computational Drug Discovery Methods
- Genomics and Rare Diseases
- Genomics and Rare Diseases
- Pharmacological Effects and Toxicity Studies
- Pharmacological Effects and Toxicity Studies
- Gene expression and cancer classification
- Gene expression and cancer classification
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Treatments and Studies
- Antiplatelet Therapy and Cardiovascular Diseases
- Antiplatelet Therapy and Cardiovascular Diseases
- Acute Lymphoblastic Leukemia research
- Acute Lymphoblastic Leukemia research
- BRCA gene mutations in cancer
- Bioinformatics and Genomic Networks
- Bioinformatics and Genomic Networks
- HIV/AIDS drug development and treatment
- HIV/AIDS drug development and treatment
- BRCA gene mutations in cancer
- Schizophrenia research and treatment
- Schizophrenia research and treatment
- Eicosanoids and Hypertension Pharmacology
- Eicosanoids and Hypertension Pharmacology
- Renal Transplantation Outcomes and Treatments
- Renal Transplantation Outcomes and Treatments
- Neurotransmitter Receptor Influence on Behavior
- Neurotransmitter Receptor Influence on Behavior
- Receptor Mechanisms and Signaling
- Receptor Mechanisms and Signaling
- Cancer therapeutics and mechanisms
- Drug-Induced Adverse Reactions
- Cancer therapeutics and mechanisms
- Drug-Induced Adverse Reactions
- Lipoproteins and Cardiovascular Health
- Lipoproteins and Cardiovascular Health
- Epigenetics and DNA Methylation
- Epigenetics and DNA Methylation
- Glutathione Transferases and Polymorphisms
- Glutathione Transferases and Polymorphisms
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ